Direct is actually better than L and one of the things real shareholders have been angry is that despite sacrificing most progress on Direct for years for the alleged sake of focusing on developing L, we have gotten neither.
Go back and look at the Phase 1 data, Direct was killing tumors so viciously that the tumors were bloating like corpses and making it look, at first like Direct was not working until the tumor was biopsied and found to be necrotic.